Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)

Summary

SB 1149 would create a reporting system in Wisconsin that obligates prescription‑drug manufacturers to notify the health department and insurance commissioner of large price increases or high‑cost new drugs, and to file annual reports on price concessions and patient assistance programs. The law also provides $184,200 each fiscal year to hire two staff members to manage the program and sets daily fines of up to $10,000 for manufacturers that fail to comply. The goal is to increase transparency around drug pricing for consumers and policymakers.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share